Background: MicroRNAs (miRNAs) are important post-transcriptional regulators of gene expression, but we have limited insight into their role in age-related cerebral pathologies. Here, we investigated the association between miRNAs and nine age-related cerebral pathologies in participants of the ROS/MAP cohorts.
Method: MiRNA sequencing was performed on samples from the dorsolateral prefrontal cortex of 617 brain donors from participants of the ROS/MAP cohorts. Following quality control, miRNAs were filtered to 528 verified miRNAs, which were included in the global miRNA differential expression (DE) analysis. A genome-wide miRNA DE analysis was performed for global Alzheimer's disease (AD) pathology, Lewy body pathology, TDP-43, hippocampal sclerosis, arteriolosclerosis, cerebral amyloid angiopathy, cerebral atherosclerosis, gross cerebral infarct, and microinfarct. Two models were tested for each outcome: first, a minimally adjusted model adjusting for potential confounding factors, and a fully adjusted model that further adjusted for co-existing cerebral pathologies to identify independently associated miRNAs. Gene set enrichment analysis (GSEA) was performed on the targets of DE miRNAs to identify the putative biological pathways underlying these pathologies.
Result: With minimally adjusted models, we found DE miRNAs in global AD pathology, Lewy body pathology, arteriolosclerosis, and cerebral amyloid angiopathy. Extending the analysis to adjust for co-existing cerebral pathologies, we identified 75 independently associated miRNAs for global AD pathology, 45 for Lewy body pathology, 3 for arteriolosclerosis, and 1 for cerebral amyloid angiopathy at FDR < 0.05. Interestingly, we found miRNAs that are shared between AD hallmark pathologies and other age-related cerebral pathologies. GSEA of target genes of the independently associated DE miRNAs identified biological pathways related to glutathione metabolism, synaptic functions, cellular transport, and innate immune responses altered in arteriolosclerosis at FDR < 0.05.
Conclusion: We identified DE miRNAs in multiple age-related cerebral pathologies. Our study unveiled shared DE miRNAs between AD hallmark pathologies and other age-related cerebral pathologies. GSEA results informed putative biological pathways altered in arteriolosclerosis. Collectively, our findings shed light on the role of miRNAs in age-related cerebral pathologies and establish a basis for future mechanistic studies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.084740 | DOI Listing |
Adv Sci (Weinh)
January 2025
School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
β-secretase (BACE1) is instrumental in amyloid-β (Aβ) production, with overexpression noted in Alzheimer's disease (AD) neuropathology. The interaction of Aβ with the receptor for advanced glycation endproducts (RAGE) facilitates cerebral uptake of Aβ and exacerbates its neurotoxicity and neuroinflammation, further augmenting BACE1 expression. Given the limitations of previous BACE1 inhibition efforts, the study explores reducing BACE1 expression to mitigate AD pathology.
View Article and Find Full Text PDFEur J Hum Genet
January 2025
Institute of Bioinformatics, International Technology Park, Bangalore, 560066, India.
Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a rare neurodegenerative disorder characterized by spastic paraplegia, parkinsonism and psychiatric and/or behavioral symptoms caused by variants in gene encoding chromosome-19 open reading frame-12 (C19orf12). We present here seven patients from six unrelated families with detailed clinical, radiological, and genetic investigations. Childhood-onset patients predominantly had a spastic ataxic phenotype with optic atrophy, while adult-onset patients were presented with cognitive, behavioral, and parkinsonian symptoms.
View Article and Find Full Text PDFCommun Biol
January 2025
Division of Geriatrics, Department of Medicine, SMPH, University of Wisconsin-Madison, Madison, WI, USA.
Changes in brain mitochondrial metabolism are coincident with functional decline; however, direct links between the two have not been established. Here, we show that mitochondrial targeting via the adiponectin receptor activator AdipoRon (AR) clears neurofibrillary tangles (NFTs) and rescues neuronal tauopathy-associated defects. AR reduced levels of phospho-tau and lowered NFT burden by a mechanism involving the energy-sensing kinase AMPK and the growth-sensing kinase GSK3b.
View Article and Find Full Text PDFActa Neuropathol Commun
January 2025
Department of Biological Sciences, Purdue University, 915 Mitch Daniels Blvd, West Lafayette, IN, USA.
Dementia refers to an umbrella phenotype of many different underlying pathologies with Alzheimer's disease (AD) being the most common type. Neuropathological examination remains the gold standard for accurate AD diagnosis, however, most that we know about AD genetics is based on Genome-Wide Association Studies (GWAS) of clinically defined AD. Such studies have identified multiple AD susceptibility variants with a significant portion of the heritability unexplained and highlighting the phenotypic and genetic heterogeneity of the clinically defined entity.
View Article and Find Full Text PDFAgeing Res Rev
January 2025
Department of Cardiovascular Center, TheFirst Hospital of Jilin University, Changchun,Jilin, China.
Sirtuin-3 (SIRT3) in mitochondria has nicotinamide adenine dinucleotide (NAD+)-dependent protein deacetylase activity. As such, SIRT3 is crucial in cardiovascular and neurodegenerative diseases. Advanced proteomics and transcriptomics studies have revealed that SIRT3 expression becomes altered when the heart or brain is affected by external stimuli or disease, such as diabetic cardiomyopathy, atherosclerosis, myocardial infarction, Alzheimer's disease, Huntington's disease, and Parkinson's disease.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!